Sean Stalfort is a director of Taysha Gene Therapies Inc.
Person profile
Roles
Taysha Gene Therapies
Director
Acumen Pharmaceuticals
Director
Address
Durham, North Carolina
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Taysha Gene Therapies, Inc.
16 Aug 23
4
Taysha Gene Therapies, Inc.
26 Jun 23
3
Taysha Gene Therapies, Inc.
26 Jun 23
4
Acumen Pharmaceuticals, Inc.
7 Jun 23
4
Verrica Pharmaceuticals Inc.
5 Jul 22
4
Acumen Pharmaceuticals, Inc.
17 Jun 22
4
Acumen Pharmaceuticals, Inc.
8 Jul 21
3/A
Acumen Pharmaceuticals, Inc.
8 Jul 21
4
Acumen Pharmaceuticals, Inc.
2 Jul 21
3
Acumen Pharmaceuticals, Inc.
30 Jun 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
16 Aug 23 | TSHA Taysha Gene Therapies | Common Stock | Gift | Acquire G | No | No | 0 | 50,000 | 0.00 | 1,049,381 |
16 Aug 23 | TSHA Taysha Gene Therapies | Common Stock | Buy | Acquire P | No | No | 0.9 | 388,889 | 350.00 k | 999,381 |
16 Aug 23 | TSHA Taysha Gene Therapies | Common Stock | Buy | Acquire P | Yes | No | 0.9 | 388,889 | 350.00 k | 884,290 |
22 Jun 23 | TSHA Taysha Gene Therapies | Stock Option Common Stock | Grant | Acquire A | No | No | 0.72 | 43,800 | 31.54 k | 43,800 |
6 Jun 23 | ABOS Acumen Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 5.2 | 25,000 | 130.00 k | 25,000 |